Skip to main content
. 2020 May 12;8(6):705–715. doi: 10.1177/2050640620924302

Table 1.

Baseline characteristics of AIP patients at diagnosis and clinical presentation.

Overall Type 1 AIP§ (n = 106) Type 2 AIP§ (n = 48) p-value NOS-AIP§ (n = 19)
Male (%) 108 (62.4) 71 (66.9) 26 (54.2) 0.13 11
Age at diagnosis (median) 61 62.5 48 <0.001 62
BMI* at diagnosis (median) 23.5 23.8 23.5 0.9 28.8
Comorbidities
 Cardiovascular 56 (32.4) 40 (37.7) 13 (27.1) 0.2 3 (15.8)
 Diabetes 18 (10.4) 13 (12.3) 3 (6.2) 0.25 2 (10.5)
 Cancers 9 (5.2) 6 (5.7) 1 (2.1) 0.3 2 (10.5)
 Pulmonary 16 (9.2) 12 (11.3) 3 (6.2) 0.32 1 (5.3)
 Rheumatological 14 (8.1) 7 (6.6) 5 (10.4) 0.41 2 (10.5)
 Gastrointestinal 28 (16.2) 8 (7.5) 17 (35.4) <0.001 3 (15.8)
 Autoimmune 15 (8.7) 11 (10.4) 3 (6.2) 0.4 1 (5.3)
 Prostatic 12 (6.9) 8 (7.5) 3 (6.2) 0.4 1 (5.3)
Other organ involvement in type 1 AIP§
 Overall 61 (57.5)
 Biliary ducts 42 (39.6)
 Salivary glands 8 (7.5)
 Kidneys 12 (11.3)
 Lymph nodes 10 (9.4)
 Retroperitoneal fibrosis 2 (1.9)
 Lungs 8 (7.5)
 Other 7 (6.6)
IBD# 21 (12.1) 2 (1.9) 13 (27.1) <0.001 2 (10.5)
Symptoms
 Dark urine 30 (17.3) 22 (20.7) 7 (14.6) 0.37 1 (5.3)
 Pale faeces 28 (16.2) 21 (19.8) 6 (12.5) 0.27 1 (5.3)
 Jaundice 70 (40.5) 52 (49.0) 12 (25.0) 0.005 6 (31.6)
 Acute pancreatitis 37 (21.4) 21 (19.8) 12 (25.0) 0.47 4 (21)
 Epigastric pain 51 (29.5) 26 (24.5) 15 (31.25) 0.38 10 (5.3)
 Radiating epigastric pain 27 (15.6) 12 (11.3) 12 (25.0) 0.03 3 (15.8)
 Lumbar pain 13 (7.5) 7 (6.6) 4 (8.3) 0.7 2 (10.5)
 Nausea 14 (8.1) 10 (9.4) 3 (6.25) 0.51 1 (5.3)
 Astenia 25 (14.4) 16 (15.1) 8 (16.7) 0.8 1 (5.3)
 Anorexia 21 (12.1) 16 (15.1) 5 (10.4) 0.43 0
 Weight loss 40 (23.1) 26 (24.5) 10 (20.8) 0.62 4 (21)
Analgesics 71 (41) 33 (31.1) 26 (54.2) 0.006 12 (63.2)

§AIP: autoimmune pancreatitis; °NOS: not otherwise specified; *BMI: body mass index; #IBD: inflammatory bowel disease.